The pandemic has set a new era into motion. One year ago last month, when the world went into…
- Member of Distinction Awardees
- Jerilyn Ross Clinician Advocate Awardees
- Special Recognition Awardee
- Emerging Leader Awardees
Cindy J. Aaronson, MSW, PhD
Icahn School of Medicine
Dr. Aaronson’s clinical interests include panic disorder, generalized anxiety disorder, social anxiety, posttraumatic stress disorder, and depression. Her research involves developing new types of treatment interventions for PTSD, depression, and interventions to encourage initiation of and adherence to hepatitis C medication treatment. Dr. Aaronson is an ADAA Clinical Fellow and has been an active member of ADAA since 2004.
Gordon Asmundson, PhD
University of Regina
Gordon J. G. Asmundson, PhD, is a Registered Doctoral Psychologist and Full Professor of Psychology at the University of Regina in Saskatchewan, Canada. He received his doctorate in Psychology from the University of Manitoba in 1991, completed postdoctoral training from 1991-1993 under supervision of Drs. Murray Stein and John Walker, and in 2005-2006 trained as a Beck Scholar at the Beck Institute for Cognitive Therapy and Research in Philadelphia. He is Editor-in-Chief of the Journal of Anxiety Disorders and Clinical Psychology Review and serves on the editorial boards for nine other journals, including ADAA’s Depression and Anxiety. His research and clinical interests are in assessment and basic mechanisms of fear, the anxiety and related disorders, and chronic pain, and the association of these with each other, maladaptive coping, and disability. Dr. Asmundson has published 325 peer-reviewed journal articles, 70 book chapters, and 8 books. He is a Fellow of the Royal Society of Canada (2009) and has received the Canadian Psychological Association (CPA) Donald O. Hebb Award for Outstanding Contributions to the Science of Psychology (2014), the CPA Traumatic Stress Section Award for Excellence in Psychology of Traumatic Stress (2018), the Canadian Pain Society Distinguished Career Award (2018), as well as a number of early career awards, including the inaugural ADAA Young Investigator Research Award (1998). He is a longstanding member of ADAA who proudly boasts having attended and contributed to the annual conference consistently for more than 25 years now.
Charles B. Nemeroff, MD, PhD
Dell Medical School/The University of Texas at Austin
Charles B. Nemeroff is the Leonard M. Miller Professor and Chairman of the Department of Psychiatry and Behavioral Sciences, and Clinical Director of the Center on Aging at the University of Miami Miller School of Medicine. He is past president of the American College of Psychiatrists and the American College of Neuropsychopharmacology. His research has focused on the neurobiology of mood and anxiety disorders with a focus on the long term consequences of child abuse and neglect and how these changes increase vulnerability for psychiatric disorders in adulthood. He has published more than 1000 research reports and reviews, and 15 books. He is a member of the Institute of Medicine of the National Academy of Sciences (USA). Dr. Nemeroff is an ADAA Clinical Fellow.
Sanjay J. Mathew, MD
Baylor College of Medicine / Michael E. Debakey VA Medical Center
Sanjay J. Mathew, MD is the Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research and Professor in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine. He is also a staff psychiatrist at the Michael E. Debakey VA Medical Center (MEDVAMC) in Houston, Texas. He graduated from Dartmouth College and Baylor College of Medicine, and completed his psychiatric residency at Columbia University and the New York State Psychiatric Institute, where he also completed a NIH-funded research fellowship in affective and anxiety disorders. Dr. Mathew began his faculty career at the Icahn School of Medicine at Mount Sinai where he co-founded and directed the Mood & Anxiety Disorders Program. In 2010, Dr. Mathew was recruited back to his hometown of Houston to direct Baylor’s Mood & Anxiety Disorders Program. His research program focuses on developing novel therapies for patients with serious, treatment-resistant mood and anxiety disorders and PTSD, with a particular focus on glutamate-modulating agents.
Dr. Mathew’s research program is funded by NIMH, Department of Veterans Affairs, Patient-Centered Outcomes Research Institute (PCORI), and industry in the areas of experimental therapeutics and pathophysiology of treatment-resistant depression, suicide, and PTSD. He has authored or co-authored over 130 manuscripts and book chapters, and serves on the editorial board of several journals. He is a member of the American College of Neuropsychopharmacology, board member of the American Society of Clinical Psychopharmacology, and was formerly Chair of the Program Committee for the Anxiety and Depression Association of America. An active clinician, Dr. Mathew has been selected by his peers as a “Best Doctor” every year since 2011.
Mary K. Alvord, PhD
Alvord, Baker & Associates, LLC
Dr. Mary Karapetian Alvord, PhD, is a psychologist with more than 35 years of clinical experience and is director of Alvord, Baker & Associates. She specializes in treating children, adolescents, and adults using cognitive behavior therapies. A central focus is building resilience in children and teens with depression, anxiety disorders, ADHD and other emotional and behavioral regulation problems. She is adjunct associate professor of psychiatry and behavioral sciences at The George Washington University School of Medicine and Health Sciences. Fellow of both the American Psychological Association and of the Association for Behavioral and Cognitive Therapies, she is also a Clinical Fellow of the Anxiety and Depression Association of America. She is co-author of Conquer Negative Thinking for Teens, Resilience-Builder Program, and audio recordings, Relaxation and Self-Regulation Techniques for Children and Teens and Relaxation and Wellness Techniques (for adults). Mary Alvord is an ADAA Clinical Fellow.
Kevin Chapman, PhD
Dr. Kevin Chapman is a Licensed Clinical Psychologist in private practice, where he engages in the assessment and treatment of anxiety and related disorders and the culturally-infused implementation of cognitive behavioral therapy (CBT). In addition to being a Media Psychologist, Dr. Chapman is the past Program Chair for the Association for Behavioral and Cognitive Therapies (ABCT), former Master Clinician Seminar Chair for ABCT and is the former Chair of the Facilitated Consultation Committee for the Anxiety and Depression Association of America (ADAA). Dr. Chapman was an Associate Professor in Psychology from the University of Louisville prior to establishing a full-time private practice in 2014.
Jill Harkavy-Friedman, PhD
American Foundation for Suicide Prevention
Dr. Jill Harkavy-Friedman is the Vice President of Research and leads the American Foundation for Suicide Prevention’s research grant program to advance the field of suicide prevention. With 30 years of experience as a clinician and a researcher, she is passionate about translating research into practice, publishing over 100 peer-reviewed articles. She assists with AFSP’s development of programs and messages that reflect best practices and current research. She works with other national and international research organizations to help set the suicide prevention research agenda and encourage innovative research.
Harkavy-Friedman earned her B.A. in Psychology at the University of Pennsylvania and her PhD. in Clinical Psychology at the University of Florida. In 1984, she joined Montefiore Medical Center/Albert Einstein College of Medicine, establishing the Adolescent Depression and Suicide Program. In 1989, she moved to Columbia University/New York State Psychiatric Institute where she is an associate professor in the department of psychiatry. She joined the staff AFSP in 2011. She maintains a clinical practice in Manhattan.
Ashley Clausen, PhD
Duke University/Durham VAMC
Dr. Ashley Clausen, PhD is a postdoctoral fellow in the Morey lab, funded through the Mid-Atlantic Mental Illness, Research, Education and Clinical Center Advanced Allied Health Fellowship program. She received her bachelor’s degree in psychology from Cornell College, and her master’s and doctoral degree in clinical psychology at the University of Tulsa and Laureate Institute for Brain Research. She completed her clinical residency at the Durham VA Healthcare System with an emphasis is trauma treatment and neuropsychological assessment. Dr. Clausen’s research has primarily focused on the neurobiology, brain function and treatment of PTSD in trauma exposed populations. Her thesis and dissertation examined the intersecting relationships with combat-PTSD, cardiovascular health and brain morphology, highlighting the impact that combat may have on endothelial function in relatively young OIF/OEF veterans. In the Morey Lab, her work continues to investigate the relationships between combat exposure, and mental, neurologic and physical health in order to better understand the impact of trauma exposure in veteran populations and to optimize psychological treatments to reduce the impact of trauma-exposure on physical health. Dr. Clausen has been a member of ADAA since 2012 and was a CDLP – Basic Neuroscience Track recipient in 2017. She became the co-vice chair of the Early Career SIG in 2018 and is looking forward to continued engagement in the ADAA community!
Krystal Lewis, PhD
Dr. Krystal M. Lewis is a licensed clinical psychologist at the National Institute of Mental Health where she works with Dr. Daniel Pine and the Section on Development and Affective Neuroscience (SDAN). She received her PhD from Virginia Tech and completed her undergraduate degree at Lincoln University. Dr. Lewis has worked extensively with anxious children and adolescents, providing evidence-based treatments as well as preventative interventions. She enjoys working with local schools and disseminating information on youth mental health. In addition, Dr. Lewis has contributed to various research projects and considers herself a clinical researcher. Her research at NIH focuses on identifying mechanisms, such as self-efficacy, which impact the effectiveness of Cognitive Behavioral Therapy with anxious youth. In addition, she has a small private practice in Chevy Chase, MD. Dr. Lewis is currently the co-chair for the Child and Adolescent SIG and vice-chair for the Early Career Professionals and Students SIG.
Stephanie Woodrow, LCPC, NCC
Stephanie Woodrow, LCPC, NCC, has worked in mental health since 2011 and currently has a private practice in the Washington, D.C. area. Stephanie received her Master of Science in Clinical Mental Health Counseling from Johns Hopkins University and spent more than a year interning at Adventist HealthCare Behavioral Health & Wellness Services’ Partial Hospitalization Program in Rockville, Maryland before joining a private practice in the Baltimore area. Prior to entering the world of mental health, Stephanie worked as a political reporter in Washington, D.C. This role afforded her the opportunity to hone her interviewing and questioning style, as well as her ability to listen and respond to others, while processing information. These skills have been invaluable in Stephanie’s work in mental health. Stephanie has participated in an advanced forum through the IOCDF’s Behavior Therapy Training Institute and has taken part in ADAA’s Alies Muskin Career Development Leadership Award Program. Currently, she is the chair of ADAA’s Early Career Professionals and Students Special Interest Group.